THE BACTERICIDAL PROTEINS OF THE EPIDERMIS
Abstract
The skin is the biggest human’s organ. It is concerned with plenty of functions, such as: providing protection against harmful factors of the external environment, both chemical and physical, or regulating temperature and the amount of evaporating water. It is responsible for receiving sensory stimuli and vitamin D3 synthesis. However, this review focuses on an underestimated role of the skin as a barrier against bacteria, maintained thanks to the human’s natural antibiotics – the antimicrobial proteins of the epidermis.
References
Yousef H, Alhajj M, Fakoya AO, Sharma S. Anatomy, skin (integument), epidermis. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2025. PMID: 29262154.
Mc Dermott R, Ziylan U, Spehner D, Bausinger H, Lipsker D, Mommaas M, et al. Birbeck Granules Are Subdomains of Endosomal Recycling Compartment in Human Epidermal Langerhans Cells, Which Form Where Langerin Accumulates. Mol Biol Cell. 2001 Dec 7;13[1]:317–35.
Eckert RL, Yaffe MB, Crish JF, Murthy S, Rorke EA, Welter JF. Involucrin—Structure and Role in Envelope Assembly. J Invest Dermatol. 1993 May;100 [5]:613–7.
Arnette C, Koetsier JL, Hoover P, Getsios S, Green KJ. In vitro model of the epidermis: Connecting protein function to 3D structure. Methods Enzymol. 2016;569:287–308.
Rippa AL, Kalabusheva EP, Vorotelyak EA. Regeneration of Dermis: Scarring and Cells Involved. Cells. 2019 Jun;8[6]:607.
Wong R, Geyer S, Weninger W, Guimberteau J-C, Wong JK. The dynamic anatomy and patterning of skin. Exp Dermatol. 2016;25[2]:92–8.
Machado Lee R, Ottolini B. An evolutionary history of defensins: a role for copy number variation in maximizing host innate and adaptive immune responses. Front Immunol. 2015;6:115. doi:10.3389/fimmu.2015.00115.
Dürr UHN, Sudheendra US, Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. BiochimBiophys Acta BBA - Biomembr. 2006 Sep 1;1758[9]:1408–25.
Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol. 2004;75[1]:39–48.
Kulig P, Kantyka T, Zabel BA, Banaś M, Chyra A, Stefańska A, et al. Regulation of Chemerin Chemoattractant and Anti-bacterial Activity by Human Cysteine Cathepsins. J Immunol Baltim Md 1950. 2011 Aug 1;187[3]:1403–10.
Schittek B, Hipfel R, Sauer B, Bauer J, Kalbacher H, Stevanovic S, et al. Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol. 2001 Dec;2[12]:1133–7.
Rieg S, Seeber S, Steffen H, Humeny A, Kalbacher H, Stevanovic S, et al. Generation of Multiple Stable Dermcidin-Derived Antimicrobial Peptides in Sweat of Different Body Sites. J Invest Dermatol. 2006 Feb;126[2]:354–65.
Baechle D, Flad T, Cansier A, Steffen H, Schittek B, Tolson J, et al. Cathepsin D is present in human eccrine sweat and involved in the postsecretory processing of the antimicrobial peptide DCD-1L. J Biol Chem. 2006 Mar 3;281[9]:5406–15.
Fräki JE. Human skin proteases. Separation and characterization of two acid proteases resembling cathepsin B1 and cathepsin D and of an inhibitor of cathepsin B1. Arch Dermatol Res. 1976 Jun 21;255[3]:317–30.
Sakurada K, Akutsu T, Fukushima H, Watanabe K, Yoshino M. Detection of dermcidin for sweat identification by real-time RT-PCR and ELISA. Forensic Sci Int. 2010 Jan;194(1–3):80–4.
van Dam A, Aalders MCG, van Leeuwen TG, Lambrechts SAG. The Compatibility of Fingerprint Visualization Techniques with Immunolabeling. J Forensic Sci. 2013 Jul;58 [4]:999–1002.
Lai Y-P, Peng Y-F, Zuo Y, Li J, Huang J, Wang L-F, et al. Functional and structural characterization of recombinant dermcidin-1L, a human antimicrobial peptide. BiochemBiophys Res Commun. 2005 Mar;328[1]:243–50.
Steffen H, Rieg S, Wiedemann I, Kalbacher H, Deeg M, Sahl H-G, et al. Naturally Processed Dermcidin-Derived Peptides Do Not Permeabilize Bacterial Membranes and Kill Microorganisms Irrespective of Their Charge. Antimicrob Agents Chemother. 2006 Aug 1;50[8]:2608–20.
Cipáková I, Gasperík J, Hostinová E. Expression and purification of human antimicrobial peptide, dermcidin, in Escherichia coli. Protein Expr Purif. 2006 Feb;45[2]:269–74.
Senyurek I, Paulmann M, Sinnberg T, Kalbacher H, Deeg M, Gutsmann T, et al. Dermcidin-Derived Peptides Show a Different Mode of Action than the Cathelicidin LL-37 against Staphylococcus aureus. Antimicrob Agents Chemother. 2009 Jun 1;53[6]:2499–509.
Paulmann M, Arnold T, Linke D, Özdirekcan S, Kopp A, Gutsmann T, et al. Structure-Activity Analysis of the Dermcidin-derived Peptide DCD-1L, an Anionic Antimicrobial Peptide Present in Human Sweat. J Biol Chem. 2012 Mar 9;287[11]:8434–43.
Niyonsaba F, Suzuki A, Ushio H, Nagaoka I, Ogawa H, Okumura K. The human antimicrobial peptide dermcidin activates normal human keratinocytes. Br J Dermatol. 2009 Feb;160[2]:243–9.
Rieg S, Garbe C, Sauer B, Kalbacher H, Schittek B. Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions. Br J Dermatol. 2004 Sep;151[3]:534–9.
Nakano T, Yoshino T, Fujimura T, Arai S, Mukuno A, Sato N, et al. Reduced Expression of Dermcidin, a Peptide Active Against Propionibacterium acnes, in Sweat of Patients with Acne Vulgaris. Acta DermVenereol. 2014;0.
Arai S, Yoshino T, Fujimura T, Maruyama S, Nakano T, Mukuno A, et al. Mycostatic effect of recombinant dermcidin against Trichophyton rubrum and reduced dermcidin expression in the sweat of tinea pedis patients. J Dermatol. 2015 Jan;42[1]:70–6.
Rieg S, Steffen H, Seeber S, Humeny A, Kalbacher H, Dietz K, et al. Deficiency of Dermcidin-Derived Antimicrobial Peptides in Sweat of Patients with Atopic Dermatitis Correlates with an Impaired Innate Defense of Human Skin In Vivo. J Immunol. 2005 Jun 15;174[12]:8003–10.
Gläser R, Köten B, Wittersheim M, Harder J. Psoriasin: key molecule of the cutaneous barrier? JDDG J Dtsch Dermatol Ges. 2011;9[11]:897–902.
Gläser R, Meyer-Hoffert U, Harder J, Cordes J, Wittersheim M, Kobliakova J, et al. The Antimicrobial Protein Psoriasin (S100A7) Is Upregulated in Atopic Dermatitis and after Experimental Skin Barrier Disruption. J Invest Dermatol. 2009 Mar 1;129[3]:641–9.
Jinquan T, Vorum H, Larsen CG, Madsen P, Rasmussen HH, Gesser B, et al. Psoriasin: A Novel Chemotactic Protein. J Invest Dermatol. 1996 Jul;107[1]:5–10.
Zheng Y, Niyonsaba F, Ushio H, Ikeda S, Nagaoka I, Okumura K, et al. Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation. Immunology. 2008 Jul;124[3]:357–67.
Rangaraj A, Ye L, Sanders AJ, Price PE, Harding KG, Jiang WG. Molecular and cellular impact of Psoriasin (S100A7) on the healing of human wounds. Exp Ther Med. 2017 May;13 [5]:2151–60.
Lehrer RI, Lichtenstein AK, Ganz T. Defensins: Antimicrobial and cytotoxic peptides of mammalian cells. J Cell Biol. 1993;121[3]:443-451.
Schneider JJ, Unholzer A, Schaller M, Schäfer-Korting M, Korting HC. Human defensins. J Mol Med. 2005 Aug;83[8]:587–95.
Niedźwiedzka-Rystwej P, Deptuła W. Defensins: An important innate element of the immune system in mammals. Szczecin, Poland: University of Szczecin, Faculty of Natural Sciences; 2008.
Yamasaki K, Gallo RL. Antimicrobial peptides in human skin disease. Eur J Dermatol. 2008;18[1]:11-21. doi:10.1684/ejd.2008.0304
Niyonsaba F, Kiatsurayanon C, Chieosilapatham P, Ogawa H. Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases. Exp Dermatol. 2017 Nov;26[11]:989–98.
Contreras G, Shirdel I, Braun MS, Wink M. Defensins: Transcriptional regulation and function beyond antimicrobial activity. Dev Comp Immunol. 2020 Mar;104:103556.
Gunathilake R. The Human Epidermal Antimicrobial Barrier: Current Knowledge, Clinical Relevance and Therapeutic Implications. Recent Patents Anti-Infect Drug Disc. 2015 Oct 21;10[2]:84–97.
Herman A, Herman AP. Antimicrobial peptides activity in the skin. Skin Res Technol. 2019 Mar;25[2]:111–7.
Dhople V, Krukemeyer A, Ramamoorthy A. The human beta-defensin-3, an antibacterial peptide with multiple biological functions. BiochimBiophys Acta BBA - Biomembr. 2006 Sep;1758[9]:1499–512.
Banaś M, Zegar A, Kwitniewski M, Zabiegło K, Marczyńska J, i wsp. The expression and regulation of chemerin in the epidermis. PLoS One. 2015;10[2]:e0117830. doi:10.1371/journal.pone.0117830
Skrzeczynska-Moncznik J, Stefanska A, Zabel B, Kapińska-Mrowiecka M, Butcher E, Cichy J. Chemerin and the recruitment of NK cells to diseased skin. Acta Biochim Pol. 2009 Jul 1;56:355–60.
Stojek M. The role of chemerin in human disease. Postępy Higieny i Medycyny Doświadczalnej. 2017;71:110–117. doi:10.5604/01.3001.0010.3795
Wittamer V, Franssen J-D, Vulcano M, Mirjolet J-F, Le Poul E, Migeotte I, et al. Specific Recruitment of Antigen-presenting Cells by Chemerin, a Novel Processed Ligand from Human Inflammatory Fluids. J Exp Med. 2003 Oct 6;198[7]:977–85.
Zabel BA, Kwitniewski M, Banas M, Zabieglo K, Murzyn K, Cichy J. Chemerin regulation and role in host defense. Am J Clin Exp Immunol. 2014 Feb 27;3[1]:1–19.
Banas M, Zabieglo K, Kasetty G, et al. Chemerin is an antimicrobial agent in human epidermis. PLoS One. 2013;8[3]:e58709. doi:10.1371/journal.pone.0058709
Banaś M. Ochronna rola chemeryny w fizjologii naskórka [dissertation]. Kraków: Uniwersytet Jagielloński – Collegium Medicum; 2015.
Mattern, A., Zellmann, T. and Beck-Sickinger, A.G. (2014), Processing, signaling, and physiological function of chemerin. IUBMB Life, 66: 19-26. https://doi.org/10.1002/iub.1242
Sander LE, Davis MJ, Boekschoten MV, Amsen D, Dascher CC, Ryffel B, et al. Sensing prokaryotic mRNA signifies microbial viability and promotes immunity. Nature. 2011 May 22;474(7351):385–9.
Kulig P, Zabel BA, Dubin G, et al. Staphylococcus aureus-derived staphopain B, a potent cysteine protease activator of plasma chemerin. J Immunol. 2007;178(6):3713-3720. doi:10.4049/jimmunol.178.6.3713
Fuentes-Duculan J, Bonifacio KM, Kunjravia N, Hawkes JE, Cueto I, Li X, et al. Autoantigens ADAMTSL5 and LL-37 are significantly upregulated in active Psoriasis and associated with dendritic cells and macrophages. Exp Dermatol. 2017 Nov;26[11]:1075–82.
Reinholz M, Ruzicka T, Schauber J. Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease. Ann Dermatol. 2012;24[2]:126.
Kenshi Y, Richard LG. Antimicrobial peptides in human skin disease. 2009;24.
Hata TR, Gallo RL. Antimicrobial Peptides, Skin Infections, and Atopic Dermatitis. Semin Cutan Med Surg. 2008 Jun;27[2]:144–50.
White JH. Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: Past, present and future. J Steroid Biochem Mol Biol. 2010 Jul;121(1–2):234–8.
Witkowska D, Bartyś A, Gamian A. Defensins and cathelicidins as natural peptide antibiotics. Postepy Hig Med Dosw. 2008;14.
Niyonsaba F, Ogawa H. Protective roles of the skin against infection: Implication of naturally occurring human antimicrobial agents β-defensins, cathelicidin LL-37 and lysozyme. J Dermatol Sci. 2005 Dec;40[3]:157–68.
Niyonsaba F, Ushio H, Nagaoka I, Okumura K, Ogawa H. The Human β-Defensins (-1, -2, -3, -4) and Cathelicidin LL-37 Induce IL-18 Secretion through p38 and ERK MAPK Activation in Primary Human Keratinocytes. J Immunol. 2005 Aug 1;175[3]:1776–84.
Fumakia M, Ho EA. Nanoparticles Encapsulated with LL37 and Serpin A1 Promotes Wound Healing and Synergistically Enhances Antibacterial Activity. Mol Pharm. 2016 Jul 5;13[7]:2318–31.
Dombrowski Y, Schauber J. Cathelicidin LL-37: A defense molecule with a potential role in psoriasis pathogenesis. Exp Dermatol. 2012;21 [5]:327–30.
Park K, Elias PM, Oda Y, Mackenzie D, Mauro T, Holleran WM, et al. Regulation of Cathelicidin Antimicrobial Peptide Expression by an Endoplasmic Reticulum (ER) Stress Signaling, Vitamin D Receptor-independent Pathway. J Biol Chem. 2011 Sep 30;286[39]:34121–30.
Campbell GR, Spector SA. Toll-like receptor 8 ligands activate a vitamin D mediated autophagic response that inhibits human immunodeficiency virus type 1. PLoS Pathog. 2012;8[11]:e1003017. doi:10.1371/journal.ppat.1003017
Lehmann B, Tiebel O, Meurer M. Expression of vitamin D 3 25-hydroxylase (CYP27) mRNA after induction by vitamin D 3 or UVB radiation in keratinocytes of human skin equivalents - a preliminary study. Arch Dermatol Res. 1999 Oct 6;291[9]:507–10.
Views:
40
Downloads:
64
Copyright (c) 2025 Marcel Bobiński, Aleksandra Bubnowska, Wiktoria Skowron, Kamil Kania, Rozalia Kujawa, Anna Rogala, Bartosz Frańczak, Konrad Rzymski, Klaudia Romejko, Justyna Bartol
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
